Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators
- PMID: 1596565
Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators
Abstract
We recently proposed that endothelium may represent the primary physiologic site of synthesis of the tissue factor pathway inhibitor (TFPI). In support of this conclusion, we have now found that the poly(A)+ RNAs obtained from rabbit and bovine lung tissues contain abundant amounts of TFPI messenger RNAs (mRNAs), whereas the poly(A)+ RNAs obtained from the liver of these animals contain less than 5% of that found in the lung tissues. Because inflammatory mediators are known to upregulate tissue factor (TF) expression by the endothelium, we have examined the effect of these agents on the TFPI expression by the cultured endothelial cells. When cultured human umbilical vein endothelial cells were stimulated (in 10% fetal bovine serum) with phorbol myristate acetate (PMA), endotoxin, interleukin-1, or tumor necrosis factor-alpha, the TF mRNA increased approximately 7- to 10-fold within 2 to 4 hours. Unstimulated cells constitutively expressed TFPI mRNA and its levels either did not change or increased slightly (up to 1.5-fold) upon stimulation with these inflammatory agents. TF mRNA abruptly declined to a negligible level and the TFPI mRNA returned essentially to the basal level at approximately 24 hours. The membrane-bound TF clotting activity of induced cells peaked between 4 and 8 hours, and finally declined. The cumulative TFPI activity secreted into the media was either unchanged or slightly higher in the induced cell cultures as compared with that present in the noninduced cultures. Endothelial cells were also cultured in 10% heat-inactivated human serum derived from plasma or whole blood. TFPI secreted into the media containing whole blood serum was consistently higher (approximately 1.5-fold at 8 hours) than that secreted into the media supplemented with serum obtained from plasma lacking the formed elements; these cells also expressed similarly increased levels of TFPI mRNA. Moreover, PMA-stimulated cells cultured in whole blood serum expressed modestly increased levels of TFPI mRNA (approximately 1.5-fold); supernatants from these cells also contained similarly increased TFPI activity. Cumulatively, our data indicate that, unlike thrombomodulin and fibrinolytic enzymes synthesized by the endothelial cells, TFPI synthesis is not downregulated and may be slightly upregulated during an inflammatory response. Inspection of the 5' flanking region of the TFPI gene showed a conserved GATA-binding motif located approximately 400 bp upstream of the proposed transcription initiation site(s). This motif by binding to the GATA-2 transcriptional factor may keep the endothelium in an 'on' state for constitutive expression of TFPI.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor.J Biol Chem. 1989 Dec 5;264(34):20705-13. J Biol Chem. 1989. PMID: 2555368
-
Regulation of tissue factor pathway inhibitor expression in smooth muscle cells.Blood. 1999 Jul 15;94(2):579-86. Blood. 1999. PMID: 10397725
-
Down-regulation of murine tissue factor pathway inhibitor mRNA by endotoxin and tumor necrosis factor-alpha in vitro and in vivo.Thromb Res. 2000 Nov 1;100(3):211-21. doi: 10.1016/s0049-3848(00)00332-7. Thromb Res. 2000. PMID: 11108908
-
Structure and biology of tissue factor pathway inhibitor.Thromb Haemost. 2001 Oct;86(4):959-72. Thromb Haemost. 2001. PMID: 11686353 Review.
-
Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH.Thromb Haemost. 1995 May;73(5):873-5. Thromb Haemost. 1995. PMID: 7482419 Review.
Cited by
-
Tenogenic Induction From Induced Pluripotent Stem Cells Unveils the Trajectory Towards Tenocyte Differentiation.Front Cell Dev Biol. 2022 Mar 9;10:780038. doi: 10.3389/fcell.2022.780038. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35372337 Free PMC article.
-
Expression of tissue factor pathway inhibitor by endothelial cells and platelets.Transfus Apher Sci. 2008 Feb;38(1):9-14. doi: 10.1016/j.transci.2007.12.001. Epub 2008 Feb 7. Transfus Apher Sci. 2008. PMID: 18261960 Free PMC article. Review.
-
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.J Clin Invest. 1993 Jun;91(6):2850-60. doi: 10.1172/JCI116529. J Clin Invest. 1993. PMID: 8514893 Free PMC article.
-
Signal transduction pathways of bacterial lipopolysaccharide-stimulated bovine vascular endothelial cells.Inflammation. 1994 Apr;18(2):221-33. doi: 10.1007/BF01534563. Inflammation. 1994. PMID: 8070906
-
Contributing role of extracellular vesicles on vascular endothelium haemostatic balance in cancer.J Extracell Vesicles. 2014 Jul 11;3. doi: 10.3402/jev.v3.24400. eCollection 2014. J Extracell Vesicles. 2014. PMID: 25045423 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous